Bruce G. Allen Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143K Buy
1,659
+49
+3% +$4.3K 0.09% 107
2026
Q1
$146K Buy
1,610
+490
+44% +$45K 0.1% 109
2025
Q4
$101K Buy
1,120
+106
+10% +$10.1K 0.07% 157
2025
Q3
$99.9K Sell
1,014
-84
-8% -$8.32K 0.07% 157
2025
Q2
$100K Buy
1,098
+254
+30% +$24.6K 0.08% 155
2025
Q1
$95.5K Sell
844
-15
-2% -$1.6K 0.08% 146
2024
Q4
$90.7K Sell
859
-5
-0.6% -$536 0.07% 158
2024
Q3
$93.3K Buy
864
+751
+665% +$82K 0.07% 167
2024
Q2
$12.3K Sell
113
-7
-6% -$825 0.01% 438
2024
Q1
$15.8K Sell
120
-12
-9% -$1.5K 0.01% 408
2023
Q4
$16.1K Buy
+132
New +$14.7K 0.01% 398

Other funds holding ZBH

Bruce G. Allen Investments's ZBH Position: Q2 2026 in Review

Bruce G. Allen Investments increased its Zimmer Biomet (ZBH) stake by 3% in Q2 2026, buying an estimated $4.3K and bringing the position to 1,659 shares worth $143K. The position accounts for 0.09% of the portfolio, ranked #107.

Bruce G. Allen Investments first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $146K in Q1 2026. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Bruce G. Allen Investments held 1,659 shares of Zimmer Biomet worth $143K as of Q2 2026.
  • Bruce G. Allen Investments bought 49 Zimmer Biomet shares in Q2 2026, an estimated $4.3K.
  • Zimmer Biomet made up 0.09% of Bruce G. Allen Investments's portfolio in Q2 2026, its #107 holding.
  • Bruce G. Allen Investments first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • Bruce G. Allen Investments's Zimmer Biomet position peaked at $146K in Q1 2026.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.